Generics Bulletin
In an exclusive interview with Generics Bulletin, Dr. Scott Liu, co-founder, and CEO of Chinese biosimilars and biologics specialist Shanghai Henlius Biotech, has set out his vision for the firm’s future in China and around the globe.
You may get more information by accessing the link below:
https://generics.pharmaintelligence.informa.com/GB149581/Shanghai-Henlius-CEO-Wants-To-Capitalize-On-FirstMover-Status
